Antihistamines for treatment of pruritus and urticaria
Pro Research Analysisby 
Searched over 200M research papers
Antihistamines for Pruritus and Urticaria: Mechanisms and Efficacy
Antihistamines, especially those targeting the H1 receptor, are widely used for treating pruritus (itch) and urticaria (hives). They are available in both first-generation (sedating) and second-generation (nonsedating) forms, with the latter preferred due to fewer side effects and better safety profiles 1459.
H1 Antihistamines: First-Line Therapy for Urticaria
Second-generation H1 antihistamines are recommended as the first-line treatment for all forms of urticaria due to their high efficacy and safety. Desloratadine is notable for being approved for all urticaria subtypes in the European Union . First-generation antihistamines can also reduce pruritus but are associated with more sedation and other side effects 249.
Efficacy in Acute and Chronic Urticaria
H1 antihistamines are effective in reducing pruritus and controlling symptoms in both acute and chronic urticaria. In acute urticaria, intravenous second-generation H1 antihistamines are preferred in emergency settings due to better outcomes and fewer adverse events compared to first-generation drugs . For chronic spontaneous urticaria, standard doses of second-generation antihistamines are effective, and increasing the dose (up to four times the standard) can further improve pruritus control in patients who do not respond to standard doses, though this may increase the risk of mild side effects like somnolence 468.
Antihistamines for Pruritus Beyond Urticaria
While antihistamines are effective for pruritus associated with urticaria, their benefit in other pruritic conditions, such as atopic dermatitis and psoriasis, is limited. This is because histamine is not the main cause of itch in these diseases, so blocking the H1 receptor does not provide significant relief 1359. Cochrane reviews have shown no significant antipruritic effect of H1 antihistamines in atopic eczema .
Role of Other Histamine Receptors
Most antihistamines target the H1 receptor, but research suggests that other histamine receptors, such as H4, may also play a role in itch. Selective H4 receptor antagonists have shown promise in reducing histamine-induced itch, indicating potential for future therapies in pruritus not controlled by current antihistamines .
Combination and Adjunctive Therapies
Adding leukotriene receptor antagonists to antihistamines does not significantly improve outcomes for pruritus or total symptom scores in chronic urticaria compared to antihistamines alone 410. Adjunctive therapy with systemic glucocorticosteroids in acute urticaria remains of unclear benefit .
Safety and Side Effects
Second-generation antihistamines are generally well tolerated, with minimal sedation and fewer anticholinergic or cardiac side effects compared to first-generation drugs. However, higher doses can increase the risk of somnolence, though serious adverse events are rare 2489.
Conclusion
Antihistamines, particularly second-generation H1 blockers, are the mainstay of treatment for urticaria and associated pruritus, offering effective symptom control with a favorable safety profile. Their role in treating pruritus from other causes is limited, and increasing the dose can help in resistant cases of chronic urticaria. Combination with leukotriene receptor antagonists or steroids does not provide clear additional benefit. Future therapies may target other histamine receptors, such as H4, for broader antipruritic effects.
Sources and full results
Most relevant research papers on this topic